Zhejiang Jingxin Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang Jingxin Pharmaceutical has a total shareholder equity of CN¥5.9B and total debt of CN¥363.8M, which brings its debt-to-equity ratio to 6.2%. Its total assets and total liabilities are CN¥8.6B and CN¥2.7B respectively. Zhejiang Jingxin Pharmaceutical's EBIT is CN¥660.7M making its interest coverage ratio -9. It has cash and short-term investments of CN¥1.1B.
Key information
6.2%
Debt to equity ratio
CN¥363.85m
Debt
| Interest coverage ratio | -9x |
| Cash | CN¥1.11b |
| Equity | CN¥5.86b |
| Total liabilities | CN¥2.72b |
| Total assets | CN¥8.58b |
Recent financial health updates
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt
Oct 04
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt
Mar 29Recent updates
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt
Oct 04Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement
Sep 12Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30
May 21Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit
Apr 08We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt
Mar 29Financial Position Analysis
Short Term Liabilities: 002020's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: 002020's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥360.4M).
Debt to Equity History and Analysis
Debt Level: 002020 has more cash than its total debt.
Reducing Debt: 002020's debt to equity ratio has reduced from 8.3% to 6.2% over the past 5 years.
Debt Coverage: 002020's debt is well covered by operating cash flow (248.8%).
Interest Coverage: 002020 earns more interest than it pays, so coverage of interest payments is not a concern.